Previous 10 | Next 10 |
Oncologie receives exclusive global license to develop and commercialize navicixizumab LONDON, and REDWOOD CITY, Calif., and BOSTON, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or the "Company," and Oncologie, Inc. (“Oncologieȁ...
Falcon Oil & Gas Ltd. (“Falcon”) Kyalla 117 N2-1H Horizontal Well Operational Update 13 January 2020 - Falcon Oil & Gas Ltd. (TSXV: FO, AIM: FOG) provides the following operational update on the drilling of the Kyalla 117 N2-1H well in the Beetaloo S...
Calgary, Alberta and Houston, Texas--(Newsfile Corp. - January 13, 2020) - PetroTal Corp. (TSXV: TAL) (AIM: PTAL) (" PetroTal " or the " Company "), the Peruvian focused E&P company, is pleased to announce 2019 year-end production of 13,300 barrels of oil per day ("bopd") from the Breta&...
ST HELIER, Jersey, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (TSX: CAL) (NYSE American: CMCL) (LSE: CMCL) ("Caledonia" or the "Company") announces record quarterly gold production from the Blanket Mine ("Blanket") in Zimbabwe for the quarter ended December 31, ...
ST HELIER, Jersey, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (the “Company” or “Caledonia”) (NYSE American: CMCL; AIM: CMCL; TSX: CAL) announces that following the maturing of a long term incentive plan award on January 19, 2020 a to...
Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant dose-dependent improvements in lung function Clinically relevant secondary endpoints met, including progressive and statistically significant improvements in quality of life Conference...
LONDON, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, will release results on Monday, January 13, 2020 at 5.00 am GMT from a Phase 2b dose-ranging stu...
LONDON, UK / ACCESSWIRE / January 10, 2020 / Condor Gold (AIM:CNR)(TSX:COG) announces that it has appointed SP Angel Corporate Finance LLP as sole Broker to the Company with immediate effect. Mark Child, Chairman and CEO commented: "On behalf of the Board I would like to thank Numis Securi...
LONDON and VANCOUVER, British Columbia, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Mkango Resources Ltd. (AIM/TSX-V: MKA) (the "Company" or "Mkango") is pleased to announce that its subsidiary, Maginito Limited (“Maginito”), has completed the acquisition of an initial 25% interest in H...
LONDON, UK / ACCESSWIRE / January 9, 2020 / We are initiating coverage of Silence Therapeutics (SLN), a developer of siRNA drugs for diseases that can be genetically targeted. Silence has a proprietary platform for developing siRNA therapeutics, the strength of which was highlighted by precl...
News, Short Squeeze, Breakout and More Instantly...
OCALA, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of new pre-clinical data concerning the company’s drug Ampligen as part of a combinational therapy in the...
OCALA, Fla., June 10, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Pitch Con...
OCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series ...